NUZOLVENCE Trademark

Trademark Overview

On Tuesday, May 21, 2024, a trademark application was filed for NUZOLVENCE with the United States Patent and Trademark Office. The USPTO has given the NUZOLVENCE trademark a serial number of 98561615. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by Entasis Therapeutics (Ireland) Limited. The NUZOLVENCE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, antibiotics; pharmaceutical preparations for the treatment of gonorrhea; pharmaceutical preparations for the treatment of sexually transmitted diseases

General Information

Serial Number98561615
Word MarkNUZOLVENCE
Filing DateTuesday, May 21, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, antibiotics; pharmaceutical preparations for the treatment of gonorrhea; pharmaceutical preparations for the treatment of sexually transmitted diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEntasis Therapeutics (Ireland) Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 4
IE
Party NameEntasis Therapeutics (Ireland) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 4
IE

Trademark Events

Event DateEvent Description
Tuesday, May 21, 2024NEW APPLICATION ENTERED
Tuesday, May 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, September 24, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 14, 2024TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Monday, December 2, 2024ASSIGNED TO PETITION STAFF
Tuesday, December 3, 2024PETITION INQUIRY LETTER ISSUED
Thursday, December 5, 2024ASSIGNED TO EXAMINER
Monday, December 9, 2024NON-FINAL ACTION E-MAILED
Monday, December 16, 2024SUSPENSION LETTER WRITTEN
Monday, December 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024NON-FINAL ACTION WRITTEN
Monday, December 9, 2024PETITION TO DIRECTOR DISMISSED
Monday, December 16, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 16, 2024LETTER OF SUSPENSION E-MAILED
Monday, December 16, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2025ASSIGNED TO LIE
Thursday, January 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 11, 2025PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

nuzolvence preparations pharmaceutical treatment transmitted diseases sexually gonorrhea namely antibiotics